Bharat Parenterals Ltd Releases Annual Report FY2025-26
Bharat Parenterals Ltd has filed its Annual Report for the Financial Year 2025-26, as per SEBI regulations. The report includes the notice for the 33rd Annual General Meeting (AGM) scheduled for September 19, 2026, to be held via Video Conferencing. The report details corporate overview, statutory reports, financial statements (standalone and consolidated), and the AGM notice. Key performance indicators highlight over 32 years of industry experience, reach in 40+ countries, 25% solar-powered operations, 3 integrated growth platforms, 48 registrations in FY2025-26, 214 dossiers across markets, and 3 subsidiaries. The report also contains forward-looking statements and information on the company's founding promoter, Mr. Rameshchandra Desai, and a message from the Chairman & Managing Director.
Key Highlights
- Annual Report for FY2025-26 filed with BSE.
- 33rd AGM scheduled for September 19, 2026, via VC/OAVM.
- Report includes financial statements and corporate governance details.
- Highlights 32+ years experience and 40+ countries reached.
- Company operates 25% on solar energy with 3 subsidiaries.
Price Impact
More from BPLPHARMA